Preservation of myocardial viability within the risk area by intravenous nicorandil before primary coronary intervention in patients with acute myocardial infarction

Nuclear Medicine Communications

Volumn 29, Issue 11, 2008, Pages 956-962

  Umemura, Shigeo ^a   Nakamura, Seishi ^a   Sugiura, Tetsuro ^a   Tsuka, Yoshiaki ^a   Shimojo, Michio ^a   Baden, Masato ^a   Iwasaka, Toshiji ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Acute myocardial infarction; Ischemic preconditioning; Myocardial viability; Nicorandil; Technetium 99m tetrofosmin

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; NICORANDIL; TETROFOSMIN TC 99M;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CELL VIABILITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE WALL MOTION; HEART PROTECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; SCINTIANGIOCARDIOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ACUTE DISEASE; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; MYOCARDIUM; NICORANDIL; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASODILATOR AGENTS;

EID: 55149106324     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32830fdde7     Document Type: Article

References (33)

1. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O'Keefe J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1993; 328:673-679.
2. De Boer MJ, Suryapranata H, Hoorntje JC, Reiffers S, Liem AL, Miedema K, et al. Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in acute myocardial infarction. Circulation 1994; 90:753-761.
3. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. Clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1997; 336:1621-1628.
4. Ito H, Taniyama Y, Iwakura K, Nishikawa N, Masuyama T, Kuzuya T, et al. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol 1999; 33:654-660.
5. Sugimoto K, Ito H, Iwakura K, Ikushima M, Kato A, Kimura R, et al. Intravenous nicorandil in conjunction with coronary reperfusion therapy is associated with better clinical and functional outcomes in patients with acute myocardial infarction. Circ J 2003; 67:295-300.
6. Ono H, Osanai T, Ishizaka H, Hanada H, Kamada T, Onodera H, et al. Nicorandil improves cardiac function and clinical outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: role of inhibitory effect on reactive oxygen species formation. Am Heart J 2004; 148:E15.
7. Ishii H, Ichimiya S, Kanashiro M, Amano T, Imai K, Murohara T, et al. Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction. Circulation 2005; 112:1284-1288.
8. Ito H, Tomooka T, Sakai N, Yu H, Higashino Y, Fujii K, et al. Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992; 85:1699-1705.
9. Ito H, Iwakura K, Oh H, Masuyama T, Hori M, Higashino Y, et al. Temporal changes in myocardial perfusion patterns in patients with reperfused anterior wall myocardial infarction. Their relation to myocardial viability. Circulation 1995; 91:656-662.
10. Lim YJ, Nanto S, Masuyama T, Kohama A, Hori M, Kamada T. Myocardial salvage: its assessment and prediction by the analysis of serial myocardial contrast echocardiograms in patients with acute myocardial infarction. Am Heart J 1994; 128:649-656.
11. Kloner RA, Ganote CE, Jennings RB. The ‘no-reflow’ phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974; 54:1496-1508.
12. Iwakura K, Ito H, Kawano S, Shintani Y, Yamamoto K, Kato A, et al. Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction. J Am Coll Cardiol 2001; 38:472-477.
13. Auchampach JA, Cavero I, Gross GJ. Nicorandil attenuates myocardial dysfunction associated with transient ischemia by opening ATP-dependent potassium channels. J Cardiovasc Pharmacol 1992; 20:765-771.
14. Imagawa J, Baxter GF, Yellon DM. Myocardial protection afforded by nicorandil and ischaemic preconditioning in a rabbit infarct model in vivo. J Cardiovasc Pharmacol 1998; 31:74-79.
15. + channels. Am Physiol 1996; 270:H1744-H1756.
16. 99mTc-tetrofosmin assessment of myocardial perfusion and viability in canine models of coronary occlusion and reperfusion. J Nucl Med 1999; 40:142-149.
17. Kaul S, Villanueva FS. Is the determination of myocardial perfusion necessary to evaluate the success of reperfusion when the infarct-related artery is open? Circulation 1992; 85:1942-1944.
18. Kaul S. Assessing the myocardium after attempted reperfusion: should we bother? Circulation 1998; 98:625-627.
19. Nakagawa Y, Ito H, Kitakaze M, Kusuoka H, Hori M, Kuzuya T, et al. Effect of angina pectorisi on myocardial protection in patients with reperfused anterior wall myocardial infarction: retrospective clinical evidence of ‘preconditioning’. J Am Coll Cardiol 1995; 25:1076-1083.
20. Hamada S, Nakamura S, Sugiura T, Murakami T, Fujimoto T, Watanabe J, et al. Early detection of the no-reflow phenomenon in reperfused acute myocardial infarction using technetium-99m tetrofosmin imaging. Eur J Nucl Med Mol Imaging 1999; 26:208-214.
21. Ito H, Tomooka T, Sakai N, Higashino Y, Fujii K, Katoh O, et al. Time course of functional improvement in stunned myocardial in risk area in patients with reperfused anterior infarction. Circulation 1993; 87:355-362.
22. Watanabe J, Nakamura S, Sugiura T, Takehana K, Hamada S, Miyoshi H, et al. Early identification of impaired myocardial reperfusion with serial assessment of ST segments after percutaneous transluminal coronary angioplasty during acute myocardial infarction. Am J Cardiol 2001; 88:956-959.
23. Nakamura S, Takehana K, Sugiura T, Hatada K, Hamada S, Asada J, et al. Quantitative estimation of myocardial salvage after primary percutaneous transluminal coronary angioplasty in patients with angiographic no reflow. Eur J Nucl Med Mol Imaging 2003; 30:383-389.
24. Hamada S, Nakamura S, Sugiura T, Nishiue T, Watanabe J, Hatada K, et al. Accuracy of technetium-99m tetrofosmin myocardial perfusion imaging in the detection of spontaneous recanalization in patients with acute anterior myocardial infarction. Eur J Nucl Med Mol Imaging 2001; 28:327-333.
25. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987; 76:142-154.
26. Rentrop KP, Cohen M, Blanke H, Phillips RA. Change in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985; 5:587-592.
27. Sandler H, Dodge HT. The use of single plane angiocardiograms for the calculation of left ventricular volume in man. Am Heart J 1968; 75:325-334.
28. Kitakaze M, Asakuma M, Kim J, Shintani Y, Asanuma H, Hamasaki T, et al. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials. Lancet 2007; 370:1483-1493.
29. Akai K, Wang Y, Sekiguchi N, Sugimura A, Kumagai T, Komaru T, et al. Vasodilatory effect of nicorandil on coronary arterial microvessels: its dependency on vessel size and the involvement of the ATP-sensitive potassium channels. J Cardiovasc Pharmacol 1995; 26:541-547.
30. Wackers FJ, Gibbons RJ, Verani MS, Kayden DS, Pellikka PA, Behrenbeck T, et al. Serial quantitative planar technetium-99m isonitrile imaging in acute myocardial infarction: efficacy for noninvasive assessment of thrombolytic therapy. J Am Coll Cardiol 1989; 14:861-873.
31. Christian TF, Schwartz RS, Gibbons RJ. Determinants of infarct size in reperfusion therapy for acute myocardial infarction. Circulation 1992; 86:81-90.
32. Clements IP, Christian TF, Higano ST, Gibbons RJ, Gersh BJ. Residual flow to the infarct zone as a determinant of infarct size after direct angioplasty. Circulation 1993; 88:1527-1533.
33. Miller TD, Christian TF, Hopfenspirger MR, Hodge DO, Gersh BJ, Gibbons RJ. Infarct size after acute myocardial infarction measured by quantitative tomographic technetium-99m sestamibi imaging predicts subsequent mortality. Circulation 1995; 92:334-341.